Related Experiment Video
Updated: May 19, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
[Recurrent cervical cancer--therapeutic options].
Agnieszka Zółciak-Siwińska1, Joanna Jońska-Gmyrek, Joanna Socha
1Centrum Onkologii-Instytut im. Marii Skłodowslej-Curie w Warszawie, Zaklad Brachyterapii, Polska. agnieszka.zolciak@wp.pl
Advanced cervical cancer often recurs despite radical treatment. This analysis examines therapeutic options for a select group of patients with isolated genital tract recurrences, balancing cure potential with quality of life.
Area of Science:
- Gynecologic Oncology
- Radiation Oncology
- Medical Oncology
Context:
- Cervical cancer presents a significant health burden in Poland, with many cases diagnosed at advanced stages (FIGO IB2-IVA).
- Standard treatment involves chemoradiation (cisplatin-based chemotherapy with external beam irradiation) followed by brachytherapy.
- Despite aggressive treatment, approximately 50% of patients experience recurrence in the genital tract and/or regional lymph nodes.
Purpose:
- To analyze therapeutic options for patients with recurrent cervical cancer, specifically those with isolated recurrences within the genital tract.
- To evaluate the feasibility and outcomes of treatment strategies in this challenging subgroup.
- To discuss the balance between achieving a permanent cure and preserving quality of life.
Summary:
- Advanced cervical cancer treatment involves chemoradiation and brachytherapy.
- Recurrence rates remain high, posing a therapeutic challenge.
- Isolated genital tract recurrences offer a chance for cure but risk significant morbidity.
Impact:
- Highlights the complex management of recurrent cervical cancer.
- Informs treatment decisions for a specific patient population.
- Emphasizes the need for tailored approaches to optimize outcomes and quality of life in gynecologic oncology.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistant Cancers
